StemSynergy Therapeutics®
"Innovative Stem Cell Research. Targeted Cancer Therapeutics."

Anthony J. Capobianco, Ph.D.

President Dr. Anthony Capobianco is a Professor and Director of the Molecular Oncology Program in the Dewitt Daughtry Department of Surgery, at the University of Miami Miller School of Medicine….

Ethan Lee, M.D.-Ph.D.

Dr. Ethan Lee is a Professor in Cell & Developmental Biology, Cancer Biology, and Pharmacology at Vanderbilt University. His lab focuses on understanding mechanisms of Wnt signaling and the development…

David J. Robbins, Ph.D.

Dr. David Robbins is a Professor and Endowed Chair in Experimental Therapeutics at Georgetown University. His research is focused on elucidating the roles Wnt and Sonic hedgehog (Shh) signaling pathways…

William A. Weiss M.D.-Ph.D.

Dr. William Weiss is a Professor of Neurology, Pediatrics, and Neurological Surgery, at the University of California, San Francisco CA. He is an expert on developmental therapeutics, focusing on Myc,…

Scientific Team

SSTI has a multidisciplinary team of scientists.

Meet the Team

Leadership

Meet the founders behind StemSynergy Therapeutics, Inc.

Founders

Science

SSTI targets essential undrugged pathways in cancers.

Scientific Programs